To claim your CME certificate, please send an email to contact@euforea.eu with your name and the total number of hours that you have participated in the sessions and a member of the EUFOREA team will provide you with a certificate to claim your credits. Please only claim credit for the time spent in the session.

9 November: 2.0 credits maximum

10 November: 8.0 credits maximum

11 November: 3.0 credits maximum

Take the survey

Session 2: What is new and relevant in Type 2 inflammation?

Moderators: Prof. Peter Hellings & Prof. Ulrich Wahn

New Directions for Research & Development (15 min)

Prof. Mina Gaga (00.25 - 16.27)

Artificial intelligence – Applying this technology for the benefit of the individual patient (15 min)

Prof. Leif Bjermer (16.44 - 35.13)

Panel Discussion (10 min)

Prof. Peter Hellings, Prof. Ulrich Wahn, Prof. Vibeke Backer and Prof. Susanne Lau (35.30 - 49.53)

Session 3: Biologics in the treatment of Type 2 inflammation

Moderators: Prof. Susanne Lau & Prof. Marcus Maurer

Update on biologics in children and adolescents with asthma (15 min)

Prof. Eckard Hamelmann (51.38 - 01.06.20)

Update on biologics in dermatology (15 min)

Prof. Marcus Maurer (01.06.34 - 01.22.12)

Update on biologics in AR (15 min)

Prof. Glenis Scadding (01.22.38 - 01.37.46)

Update on biologics in CRSwNP (15 min)

Prof. Adam Chaker (01.38.00 - 01.58.52)

Panel Discussion (10 min)

Prof. Susanne Lau, Prof. Marcus Maurer, Prof. Peter Hellings, Prof. Eckard Hamelmann and Dr. Dermot Ryan (01.59.00 - 02.12.53)

Session 4: Dealing with Type2 inflammation in children and young adults

Moderators: Prof. Susanne Lau & Prof. Ulrich Wahn

The challenges in the management of children (up to 12 years) with AR, asthma and AD (15 min)

Prof. Matthias Kopp (02.13.46 - 02.32.27)

Action plan to address the challenges of the paediatric population (15 min)

Prof. Susanne Lau (02.32.59 - 02.47.26)

Industry perspective on addressing paediatric needs (15 min)

Prof. Eike Wüstenberg (02.48.58 - 03.05.23)

Allergen Immunotherapy as a modifier of Type 2 Inflammation (15 min)

Prof. Philippe Gevaert (03.05.51 - 03.19.50)

Panel Discussion (10 min)

Prof. Susanne Lau, Prof. Ulrich Wahn, Prof. Monika Gappa, Prof.Vibeke Backer and Dr. Dermot Ryan (03.19.51 - 03.33.15)

Session 5: Patient Advocacy

Moderator: Prof. Susanne Lau & Prof. Monika Gappa

EUFOREAs efforts in the field

Prof. Peter Hellings (03.33.44 - 03.44.47)

Digital and health literacy - translating science into clinical practice

Dr Stephanie Dramburg (03.45.50 - 03.58.14)

More than just drugs: Educational programs: differences within Europe and unmet needs – doctors` and patients` perspectives

Mrs Marcia Podesta (03.59.53 - 04.19.02)

Ethical Considerations in Respiratory Care

Prof. Peter Hellings (04.19.23 - 04.33.08)

Panel Discussion (10 min)

Prof. Susanne Lau, Prof. Monika Gappa, Prof. Peter Hellings, Dr Stephanie Dramburg and Prof. Kirsten Beyer (04.33.09 - 04.48.00)

Session 1: EUFOREA standards in respiratory care

Moderators: Prof. Susanne Lau & Prof. Ulrich Wahn

Paediatric perspectives in the respiratory field (15 min)

Prof. Milos Jesenak (03.25 - 20.40)

Lessons from registries across Europe (15 min)

Prof. Vibeke Backer (21.16 - 34.00)

EUFOREAs ambitions: achievements and mission (15 min)

Prof. Peter Hellings (34.28 - 51.59)

Panel Discussion (10 min)

Prof. Susanne Lau, Prof. Ulrich Wahn, Prof. Vibeke Backer, Dr. Dermot Ryan and Prof. Peter Hellings (52.00 - 01.08.00)